Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Interest Expenses (2022 - 2025)

HCW Biologics (HCWB) has disclosed Interest Expenses for 4 consecutive years, with $148387.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Expenses fell 33.57% year-over-year to $148387.0, compared with a TTM value of $870152.0 through Sep 2025, up 128.02%, and an annual FY2024 reading of $631137.0, up 122.98% over the prior year.
  • Interest Expenses was $148387.0 for Q3 2025 at HCW Biologics, down from $228714.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $255822.0 in Q1 2025 and bottomed at -$1423.0 in Q4 2023.
  • Average Interest Expenses over 4 years is $138573.7, with a median of $121950.5 recorded in 2023.
  • The sharpest move saw Interest Expenses plummeted 101.51% in 2023, then soared 16771.05% in 2024.
  • Year by year, Interest Expenses stood at $94476.0 in 2022, then tumbled by 101.51% to -$1423.0 in 2023, then skyrocketed by 16771.05% to $237229.0 in 2024, then crashed by 37.45% to $148387.0 in 2025.
  • Business Quant data shows Interest Expenses for HCWB at $148387.0 in Q3 2025, $228714.0 in Q2 2025, and $255822.0 in Q1 2025.